UNRESECTABLE MALIGNANT NEOPLASM
Clinical trials for UNRESECTABLE MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for UNRESECTABLE MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise for inoperable esophageal cancer
Disease control CompletedThis Phase 2 trial tested whether adding the immunotherapy drug durvalumab to standard chemoradiation (FOLFOX and radiation) helps patients with unresectable esophageal cancer. 112 patients were randomly assigned to receive either chemoradiation alone or chemoradiation plus durva…
Matched conditions: UNRESECTABLE MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
French study checks if new combo works for mesothelioma in everyday practice
Knowledge-focused CompletedThis study looks back at 204 patients with untreated, inoperable malignant pleural mesothelioma who received a combination of two immunotherapy drugs, nivolumab and ipilimumab, through an early access program in France. Researchers will collect data from medical records to see ho…
Matched conditions: UNRESECTABLE MALIGNANT NEOPLASM
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC